Clinical management of brain metastasis
Author:
- 1 March 1998
- journal article
- review article
- Published by Springer Nature in Journal of Neurology
- Vol. 245 (3) , 127-131
Abstract
Brain metastasis is a common complication ocurring in about 15–20% of all cancer patients. For the initial management, distinguishing between three types of presentation is essential: de novo brain metastasis, simultaneous presentation of both brain metastasis and the primary tumour (usually lung carcinoma), and the presentation of a patient known to have systemic cancer developing a brain metastasis. For de novo brain metastasis, surgery is required, and detecting the primary tumour is of limited value. For simultaneous presentation, both a craniotomy and a thoracotomy may be indicated and may lead to cure in a number of cases. For a sequential presentation, the outcome is determined by a number of independent prognostic factors: age, performance status, and the extent of metastatic disease. In relatively young patients with a single brain metastasis, good performance status and no progression of systemic disease, treatment by either surgery or radiosurgery in combination with whole brain radiation therapy is indicated. Otherwise, as in multiple brain metastases, radiation therapy only is the main treatment. For symptomatic therapy of brain oedema or increased intracranial pressure, dexamethasone is administered. The standard doses of dexamethasone may vary between 4 and 16 mg/day, depending on the severity of symptoms.Keywords
This publication has 34 references indexed in Scilit:
- Surgery versus radiosurgery in the treatment of brain metastasisJournal of Neurosurgery, 1996
- Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgeryAnnals of Neurology, 1993
- A Randomized Trial of Surgery in the Treatment of Single Metastases to the BrainNew England Journal of Medicine, 1990
- Surgical Management of Lung Cancer with Solitary Cerebral MetastasisThe Annals of Thoracic Surgery, 1988
- Rationale for Surgical Treatment of Brain Metastasis in Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 1986
- Chemotherapy induces regression of brain metastases in breast carcinomaCancer, 1986
- Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic SeizuresNew England Journal of Medicine, 1985
- Cerebrovascular Complications in Patients with CancerMedicine, 1985
- Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- The single supratentorial lesionJournal of Neurosurgery, 1980